166 related articles for article (PubMed ID: 11560490)
1. Structure and backbone dynamics of Apo-CBFbeta in solution.
Wolf-Watz M; Grundström T; Härd T
Biochemistry; 2001 Sep; 40(38):11423-32. PubMed ID: 11560490
[TBL] [Abstract][Full Text] [Related]
2. The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.
Bäckström S; Wolf-Watz M; Grundström C; Härd T; Grundström T; Sauer UH
J Mol Biol; 2002 Sep; 322(2):259-72. PubMed ID: 12217689
[TBL] [Abstract][Full Text] [Related]
3. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.
Tahirov TH; Inoue-Bungo T; Morii H; Fujikawa A; Sasaki M; Kimura K; Shiina M; Sato K; Kumasaka T; Yamamoto M; Ishii S; Ogata K
Cell; 2001 Mar; 104(5):755-67. PubMed ID: 11257229
[TBL] [Abstract][Full Text] [Related]
4. CBFbeta allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium.
Yan J; Liu Y; Lukasik SM; Speck NA; Bushweller JH
Nat Struct Mol Biol; 2004 Sep; 11(9):901-6. PubMed ID: 15322525
[TBL] [Abstract][Full Text] [Related]
5. Energetic and functional contribution of residues in the core binding factor beta (CBFbeta ) subunit to heterodimerization with CBFalpha.
Tang YY; Shi J; Zhang L; Davis A; Bravo J; Warren AJ; Speck NA; Bushweller JH
J Biol Chem; 2000 Dec; 275(50):39579-88. PubMed ID: 10984496
[TBL] [Abstract][Full Text] [Related]
6. A mutation in the S-switch region of the Runt domain alters the dynamics of an allosteric network responsible for CBFbeta regulation.
Li Z; Lukasik SM; Liu Y; Grembecka J; Bielnicka I; Bushweller JH; Speck NA
J Mol Biol; 2006 Dec; 364(5):1073-83. PubMed ID: 17059830
[TBL] [Abstract][Full Text] [Related]
7. Cooperative binding of DNA and CBFbeta to the Runt domain of the CBFalpha studied via MD simulations.
Habtemariam B; Anisimov VM; MacKerell AD
Nucleic Acids Res; 2005; 33(13):4212-22. PubMed ID: 16049027
[TBL] [Abstract][Full Text] [Related]
8. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
9. Biophysical characterization of interactions between the core binding factor alpha and beta subunits and DNA.
Tang YY; Crute BE; Kelley JJ; Huang X; Yan J; Shi J; Hartman KL; Laue TM; Speck NA; Bushweller JH
FEBS Lett; 2000 Mar; 470(2):167-72. PubMed ID: 10734228
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta.
Warren AJ; Bravo J; Williams RL; Rabbitts TH
EMBO J; 2000 Jun; 19(12):3004-15. PubMed ID: 10856244
[TBL] [Abstract][Full Text] [Related]
11. Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1).
Gu TL; Goetz TL; Graves BJ; Speck NA
Mol Cell Biol; 2000 Jan; 20(1):91-103. PubMed ID: 10594012
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and preliminary X-ray analyses of quaternary, ternary and binary protein-DNA complexes with involvement of AML1/Runx-1/CBFalpha Runt domain, CBFbeta and the C/EBPbeta bZip region.
Tahirov TH; Inoue-Bungo T; Sasaki M; Shiina M; Kimura K; Sato K; Kumasaka T; Yamamoto M; Kamiya N; Ogata K
Acta Crystallogr D Biol Crystallogr; 2001 Jun; 57(Pt 6):850-3. PubMed ID: 11375505
[TBL] [Abstract][Full Text] [Related]
13. Backbone amide dynamics studies of Apo-L75F-TrpR, a temperature-sensitive mutant of the tryptophan repressor protein (TrpR): comparison with the (15)N NMR relaxation profiles of wild-type and A77V mutant Apo-TrpR repressors.
Goel A; Tripet BP; Tyler RC; Nebert LD; Copié V
Biochemistry; 2010 Sep; 49(37):8006-19. PubMed ID: 20718459
[TBL] [Abstract][Full Text] [Related]
14. RUN-CBFbeta interaction in C. elegans: computational prediction and experimental verification.
Suad O; Eyal E; Blumenzweig I; Kessler N; Levanon D; Groner Y; Shakked Z
J Biomol Struct Dyn; 2007 Feb; 24(4):343-58. PubMed ID: 17206850
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera.
Huang G; Shigesada K; Wee HJ; Liu PP; Osato M; Ito Y
Blood; 2004 Apr; 103(8):3200-7. PubMed ID: 15070703
[TBL] [Abstract][Full Text] [Related]
16. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
Nagata T; Werner MH
J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
[TBL] [Abstract][Full Text] [Related]
17. Identification of the regions involved in DNA binding by the mouse PEBP2alpha protein.
Pérez-Alvarado GC; Munnerlyn A; Dyson HJ; Grosschedl R; Wright PE
FEBS Lett; 2000 Mar; 470(2):125-30. PubMed ID: 10734220
[TBL] [Abstract][Full Text] [Related]
18. The evolutionary origin of the Runx/CBFbeta transcription factors--studies of the most basal metazoans.
Sullivan JC; Sher D; Eisenstein M; Shigesada K; Reitzel AM; Marlow H; Levanon D; Groner Y; Finnerty JR; Gat U
BMC Evol Biol; 2008 Aug; 8():228. PubMed ID: 18681949
[TBL] [Abstract][Full Text] [Related]
19. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta.
Thirunavukkarasu K; Mahajan M; McLarren KW; Stifani S; Karsenty G
Mol Cell Biol; 1998 Jul; 18(7):4197-208. PubMed ID: 9632804
[TBL] [Abstract][Full Text] [Related]
20. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]